ONABOTULINUMTOXINA HAS A POSITIVE SAFETY AND EFFICACY PROFILE IN OVERACTIVE BLADDER (OAB) PATIENTS <65 AND ≥65 YEARS OF AGE

被引：0
作者：
Moore, Courtenay [1 ]
Kaufmann, Albert [2 ]
Joshi, Manher [3 ]
Zheng, Yan [4 ]
Herschorn, Sender [5 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Kliniken Maria Hilf GmbH, Monchengladbach, Germany
[3] Allergan Pharmaceut Inc, Irvine, CA USA
[4] Allergan Pharmaceut Inc, Bridgewater, NJ USA
[5] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
34
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
[41]   SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN BIOLOGICAL TREATMENT OVER 65 YEARS OF AGE [J].
Crespo Golmar, A. ;
Moriano, C. ;
Gonzalez Fernandez, I. ;
Larco Rojas, X. E. ;
Lopez Robles, A. ;
Perez Sandoval, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :1267-1267
[42]   Effects of socioeconomic status on the control of hypertension in patients <65 and ≥65 years of age in Taiwan: a nationwide cross-sectional study [J].
Lin, Sheng-Feng ;
Kuo, Tzu-Tung ;
Pan, Wh ;
Bai, Chyi Huey .
BMJ OPEN, 2022, 12 (02)
[43]   Analysis of overactive bladder and urinary incontinence in males in the age range between 50 and 65 years. EPICC study [J].
Martinez-Agullo, E. ;
Ruiz Cerda, J. L. ;
Arlandis Guzman, S. ;
Rebollo, P. ;
Perez, M. ;
Chaves, J. .
ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (06) :543-548
[44]   Re: A Pooled Analysis of the Efficacy of Fesoterodine for the Treatment of Overactive Bladder, and the Relationship between Safety, Co-Morbidity and Polypharmacy in Patients Aged 65 Years or Older Editorial Comment [J].
Griebling, Tomas L. .
JOURNAL OF UROLOGY, 2018, 200 (03) :477-478
[45]   Efficacy and Tolerability of Solifenacin in Patients Aged ≥ 65 Years with Overactive Bladder: Post-Hoc Analysis of 2 Open-Label Studies [J].
Capo', James P. ;
Lucente, Vincent ;
Forero-Schwanhaeuser, Sergio ;
He, Weizhong .
POSTGRADUATE MEDICINE, 2011, 123 (01) :94-104
[46]   THE EFFICACY AND SAFETY OF MIRABEGRON RELATIVE TO ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER NOT APPROPRIATELY MANAGED WITH AN ANTIMUSCARINIC: A NETWORK META-ANALYSIS [J].
Lozano-Ortega, G. ;
Gooch, K. ;
Walker, D. ;
Rogula, B. ;
Deighton, A. ;
Johnston, K. M. ;
Dmochowski, R. .
VALUE IN HEALTH, 2018, 21 :S266-S266
[47]   Darifenacin treatment of patients ≥65 years with overactive bladder:: results of a randomized, controlled, 12-week trial [J].
Chapple, C. ;
DuBeau, C. ;
Ebinger, U. ;
Rekeda, L. ;
Viegas, A. .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) :2347-2358
[48]   Mobilization in patients over 65 years of age and patients between 55 to 65 years of age is similar in terms of safety and success in Multiple Myeloma and lymphoma patients: A Single Center Experience [J].
Cekdemir, D. ;
Atesoglu, E. Birtas ;
Bai, C. ;
Dora, I. ;
Kosan, B. ;
Er, E. ;
Baskan, N. ;
Saritas, B. ;
Kural, S. ;
Gucyener, E. ;
Sengezer, M. ;
Tiryaki, N. ;
Gulbas, Z. .
BONE MARROW TRANSPLANTATION, 2015, 50 :S130-S131
[49]   Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study [J].
Robyn K. Pollom ;
Timothy Costigan ;
Lyndon B. Lacaya ;
Liza L. Ilag ;
Priscilla A. Hollander .
Diabetes Therapy, 2018, 9 :827-837
[50]   The Safety Profile of Tegaserod 6 Mg BID in Irritable Bowel Syndrome With Constipation in Women &lt;65 Years of Age Without Cardiovascular Disease History [J].
Shah, Eric D. ;
Lacy, Brian E. ;
Chey, William D. ;
Chang, Lin ;
Brenner, Darren M. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S247-S247
12345